| Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan (NCT00747578) | Taichung Veterans General Hospital | 2008-09-01 |
| Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs (NCT01083693) | Abbott | 2008-09-01 |
| Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study (NCT02489760) | Chung Shan Medical University | 2008-07-01 |
| Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment (NCT00902005) | Revmatismesykehuset AS | 2008-04-01 |
| Tramadol/Acetaminophen(Ultracet) AS add-on Therapy in the Treatment of Patients With Ankylosing Spondylitis (NCT00647517) | Chung Shan Medical University | 2008-03-01 |
| A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis (NCT00667355) | Abbott | 2008-02-01 |
| Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis (NCT00558506) | Charite University, Berlin, Germany | 2008-01-01 |
| Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care (NCT01163916) | Abbott | 2008-01-01 |
| Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis (NCT00953979) | Gu Jieruo | 2008-01-01 |
| PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity (NCT00576706) | Korea Otsuka Pharmaceutical Co., Ltd. | 2007-12-01 |
| Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis (NCT00544557) | Pfizer | 2007-10-01 |
| Infliximab and Methotrexate in Ankylosing Spondylitis (NCT00507403) | University Hospital, Tours | 2007-10-01 |
| Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy (NCT00517101) | Tel-Aviv Sourasky Medical Center | 2007-09-01 |
| Exactech Shoulder Post Market Clinical Follow-up Study (NCT05603728) | Exactech | 2007-07-19 |
| Post Marketing Surveillance of Remicade (NCT00724529) | Janssen Korea, Ltd., Korea | 2007-06-01 |
| Surveillance of Humira Injection in Korean Patients (NCT01083121) | AbbVie (prior sponsor, Abbott) | 2007-04-01 |
| Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis (NCT00420238) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| Metal on Metal Versus Metal on Highly Crossed Linked Polyethylene Sytem (NCT01422564) | Nova Scotia Health Authority | 2007-01-01 |
| Extension Study Evaluating Etanercept in Ankylosing Spondylitis (NCT00410046) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain (NCT00873730) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-12-01 |
| Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. (NCT00367211) | POZEN | 2006-09-01 |
| Study Evaluating Etanercept in Patients With Ankylosing Spondylitis (NCT00458185) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-08-01 |
| Etoricoxib Prescribing Patterns and Adverse Events of Interest in Primary Care in the United Kingdom (MK-0663-162 AM1) (NCT01685424) | Organon and Co | 2006-06-30 |
| Study Evaluating the Safety of Etanercept in Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriatic Arthritis (NCT00273858) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-03-01 |
| An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) (NCT00478660) | Abbott | 2006-02-01 |
| Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS) (NCT01079182) | AbbVie (prior sponsor, Abbott) | 2006-01-01 |
| Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis (NCT00237419) | Rheumazentrum Ruhrgebiet | 2005-12-01 |
| Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis (NCT00247962) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-12-01 |
| Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects (NCT00126724) | Targeted Genetics Corporation | 2005-08-01 |
| Study Investigating Enbrel Treatment for Ankylosing Spondylitis (NCT00195416) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-06-01 |
| D2E7-Early AS (NCT00235105) | Charite University, Berlin, Germany | 2005-03-01 |
| Combination Methotrexate and Infliximab (NCT00432432) | Chinese University of Hong Kong | 2005-02-01 |
| Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS) (NCT02840695) | Uppsala University | 2005-01-01 |
| Progression of Spinal Fusion in Ankylosing Spondylitis (NCT00085995) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2004-12-03 |
| TNFalfa Blocking Treatment of Spondylarthropathies (NCT00133315) | Hvidovre University Hospital | 2004-09-01 |
| Referral Recommendations for Axial Spondyloarthritis (NCT00383617) | Charite University, Berlin, Germany | 2004-07-01 |
| Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis (NCT00418548) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-06-01 |
| Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study (NCT01038011) | University of Zurich | 2004-06-01 |
| A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) (NCT01078558) | AbbVie (prior sponsor, Abbott) | 2004-05-13 |
| Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis (NCT00227227) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-05-01 |
| An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis (NCT00444340) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-04-01 |
| The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists (NCT00224562) | Assistance Publique - Hôpitaux de Paris | 2004-02-01 |
| Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis (NCT00085644) | Abbott | 2004-01-01 |
| Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis (NCT00195819) | Abbott | 2003-12-01 |
| Methotrexate in Ankylosing Spondylitis (MTX in AS) (NCT00243750) | Charite University, Berlin, Germany | 2003-09-01 |
| Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis (NCT00439283) | Association de Recherche Clinique en Rhumatologie | 2003-04-01 |
| Genetic Determinants of Ankylosing Spondylitis Severity (NCT00056849) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2003-03-24 |
| Remicade in the Treatment of Patients With Active Ankylosing Spondylitis (NCT01850121) | Göteborg University | 2003-01-01 |
| A Study of Infliximab (Remicade) in Patients With Ankylosing Spondylitis. (NCT00207701) | Centocor, Inc. | 2002-09-01 |
| A Study Of Celecoxib Versus Diclofenac In Patients With Ankylosing Spondylitis (NCT02528201) | Pfizer | 2002-09-01 |
| An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis (NCT00421980) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-06-01 |
| Prednisolone in Active Ankylosing Spondylitis (AS) (NCT00244166) | Charite University, Berlin, Germany | 2002-05-01 |
| 16.0040 Ankylosing Spondylitis Study (NCT00356356) | Amgen | 2002-04-01 |
| Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis (NCT00421915) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-03-01 |
| Etanercept (Enbrel) in Ankylosing Spondylitis (NCT01289743) | Charite University, Berlin, Germany | 2002-02-01 |
| Genetics of Ankylosing Spondylitis (NCT00081562) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1999-09-01 |
| Evaluation of a Patient Education Program for Ankylosing Spondylitis (NCT00722514) | Rehazentrum Bad Eilsen | 1998-07-01 |
| Prevention of Arthritis-Related Work Disability (NCT00000416) | Boston University Charles River Campus | 1997-09-01 |
| Phase II Pilot Study of Olsalazine for Ankylosing Spondylitis (NCT00004288) | National Center for Research Resources (NCRR) | 1996-05-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
| 99m-Technetium- Glucosamine in Arthritis (NCT01789151) | University of Sydney | |